Yehua Shen
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| HAIC Combined With PD-L1 Plus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma After Immunotherapy Failure (NCT06375317) | Yehua Shen | 2024-04-30 |
Track Yehua Shen automatically
Every clearance here is in the API, with alerts when new ones post.